July 13, 2017 / 1:04 PM / 10 days ago

BRIEF-Philips receives FDA clearance to market Bluecontrol

1 Min Read

July 13 (Reuters) - KONINKLIJKE PHILIPS NV:

* PHILIPS RECEIVES U.S. FDA 510(K) CLEARANCE TO MARKET ITS PHILIPS BLUECONTROL, A WEARABLE LIGHT THERAPY DEVICE TO TREAT MILD PSORIASIS AT HOME

* ‍IN U.S., BLUECONTROL IS A CLASS II PRESCRIPTION MEDICAL DEVICE DESIGNED FOR HOME USE.​

* TO PREPARE FOR COMMERCIAL LAUNCH OF BLUECONTROL IN U.S. MARKET IN EARLY 2018. SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below